Table 2.
Response rate in unadjusted patients (i.e. all patients sample).
Category | P n (%) | P + CHT n (%) |
---|---|---|
CR | 24 (4.2) | 1 (1.4) |
PR | 233 (40.4) | 51 (72.9) |
SD | 198 (34.4) | 11 (15.7) |
PD | 121 (21.0) | 7 (10.0) |
Unknown | 130 | 17 |
CR = complete response; P = pembrolizumab; P + CHT = pembrolizumab + chemotherapy; PD = progressive disease; PR = partial response; SD = stable disease